Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Other Accumulated Expenses (2024 - 2025)

Biofrontera has reported Other Accumulated Expenses over the past 2 years, most recently at $320000.0 for Q4 2025.

  • Quarterly results put Other Accumulated Expenses at $320000.0 for Q4 2025, down 47.8% from a year ago — trailing twelve months through Dec 2025 was $320000.0 (down 47.8% YoY), and the annual figure for FY2025 was $320000.0, down 47.8%.
  • Other Accumulated Expenses for Q4 2025 was $320000.0 at Biofrontera, down from $681000.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for BFRIW hit a ceiling of $683000.0 in Q2 2025 and a floor of $320000.0 in Q4 2025.